Snider Financial Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-21,885
Closed -$183K 56
2022
Q2
$183K Buy
21,885
+10,803
+97% +$151K 0.1% 55
2022
Q1
$253K Buy
11,082
+214
+2% +$5.23K 0.12% 58
2021
Q4
$302K Buy
10,868
+431
+4% +$11.5K 0.13% 55
2021
Q3
$293K Buy
10,437
+285
+3% +$8.08K 0.13% 57
2021
Q2
$280K Buy
+10,152
New +$308K 0.13% 56

Other funds holding BHC

Snider Financial Group's BHC Position: Q3 2022 in Review

Snider Financial Group sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 21,885 shares — an estimated $183K sold.

Snider Financial Group first reported a position in BHC in Q2 2021 and held it in 5 quarters. The position peaked at $302K in Q4 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Snider Financial Group reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Snider Financial Group sold 21,885 Bausch Health shares in Q3 2022, an estimated $183K.
  • Snider Financial Group first reported a position in Bausch Health in Q2 2021 and held it in 5 quarters.
  • Snider Financial Group's Bausch Health position peaked at $302K in Q4 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Snider Financial Group's 13F filing for Q3 2022, filed 14 Nov 2022.